EBIQUITY PLC

Share Issue/Capital Change • Jan 31, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6266B

Ebiquity PLC

31 January 2020

Ebiquity Plc

("the Company")

Issue of Shares

Ebiquity plc announces it has issued 10,000 ordinary shares of 25 pence each in the capital of the Company ("Ordinary Shares") following the exercise of options under the Company's share option schemes.

Application has been made for the new Ordinary Shares to be admitted to AIM, with an admission date expected to be 06 February 2020.  Upon admission, the shares will rank parri passu in all respects with the existing Ordinary Shares of the Company.

Following the anticipated admission of these shares, the total number of ordinary shares in issue will be 80,125,626 with each share carrying the right to one vote. The Ebiquity plc 2000 Employee Benefit Trust holds 4,200,000 issued Ordinary Shares to satisfy certain awards for the Company's senior management team. To date these awards have not been exercised and the trustee has agreed not to vote the Ordinary Shares held by it. As such 4,200,000 Ordinary Shares are treated as not carrying voting rights. The figure of 75,925,626 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

31 January 2020

Enquiries: Ebiquity plc Mark Sanford (Company Secretary)	020 7650 9600
Numis Securities Limited Nick Westlake (NOMAD) Matt Lewis (Corporate Broker)	020 7260 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

IOEFZGFMDMNGGZM